Diacurimap Plus 10/5mg Product Information
Diacurimap Plus 10/5 mg is a high-efficacy combination therapy designed for adults with Type 2 Diabetes. Manufactured by Multi-Apex Pharma, it combines two distinct mechanisms of action to provide superior glycemic control and cardiovascular protection.
Each film-coated tablet contains:
Empagliflozin (10 mg): An SGLT2 inhibitor that helps the kidneys remove glucose through urine.
Linagliptin (5 mg): A DPP-4 inhibitor that boosts insulin production and lowers glucose production in the liver.
Standard Dose: One tablet daily, or as directed by your physician.
Administration: Can be taken with or without food.
Storage: Store in a cool, dry place below 30°C, away from direct sunlight.
Precautions: Not for Type 1 Diabetes or Diabetic Ketoacidosis. Consult your doctor if you have kidney impairment or a history of pancreatitis.
Potential Side Effects: May include increased urination, urinary tract infections (UTIs), or mild dehydration.
Monitoring: Regular blood sugar checks are recommended to track treatment progress.



